Iris Pharma is a French CRO

Iris Pharma is a French Contract Research Organization (CRO) dedicated to strategic consulting, preclinical research, pre-clinical formulation, bioanalytical testing and clinical research in ophthalmology.

Founded in 1989 by Pierre-Paul Elena, Ph.D., Iris Pharma provides ocular drug development services to Biotechnology and Pharmaceutical Industries. Iris Pharma groups different areas of complementary activities using a state-of-the-art apparatus such as Heidelberg Retina Tonograph 2 (HRT2) and digital slit lamp.

Iris Pharma has a unique and extensive experience

Thanks to its unique and extensive experience in ophthalmology, Iris Pharma supplies the necessary understanding and competences to guide your new pharmaceutical drugs through the drug development process.

Based on Dr Pierre-Paul Elena's 27 year expertise in ophthalmology and on more than 45 highly experienced staff, Iris Pharma performs professional quality studies in preclinical research, pre-clinical formulation, bioanalytical testing and clinical trials in ophthalmology.

Iris Pharma's Research Department never stops exploring; besides animal research models of glaucoma, different models related to diabetic Retinopathy Research are currently under development.